Ergomed - About the company
Ergomed is an acquired company based in Guildford (United Kingdom), founded in 1997. It operates as a Clinical CRO specializing in oncology and rare diseases. Ergomed has raised an undisclosed amount in funding. The company has 343 active competitors, including 14 funded and 115 that have exited. Its top competitors include companies like TFS, Parexel and Syneos Health.
Company Details
Ergomed is a CRO operating in 50+ countries with two complementary businesses. As part of its co-development business, the company offers drug development services in exchange for revenues and out-licensing milestones w.r.t the sale and development of the product. The company has signed 5 such deals so far with different pharma companies. The company has acquired Haemostatix, along with a pipeline of proprietary development products for haemostasis in surgical settings.
- Website
- ergomedplc.com
- Registered Address
- 1 OCCAM COURT,SURREY RESEARCH PARK,GUILDFORD,ENGLAND,GU2 7HJ
Key Metrics
Founded Year
1997
Location
Guildford, United Kingdom
Stage
Acquired
Latest Funding Round
Investors
Ranked
13th among 343 active competitors
Annual Revenue
£145M as on Dec 31, 2022
Employee Count
1,437 as on Jan 31, 2022
Exit Details
Acquired by Permira (Sep 04, 2023)
Legal entities associated with Ergomed
Ergomed is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Ergomed Clinical Research India Private Limited CIN: U73200PN2013PTC244709 , India, Active | Nov 05, 2013 | $6.07M (As on Mar 31, 2025) | 97 (As on Mar 31, 2024) | |
ERGOMED PLC CIN: 4081094 , United Kingdom, Active | Sep 28, 2000 | $180M (As on Dec 31, 2022) | 1437 (As on Jan 31, 2022) |
Ergomed's acquisition details
Click here to take a look at Ergomed's acquisition in detail
Sign up to download Ergomed's company profile
Ergomed's funding and investors
Ergomed has raised funding over 2 rounds. Its first funding round was on 2005. Ergomed has 1 institutional investor.
Here is the list of recent funding rounds of Ergomed:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Feb 01, 2018 | 5200930 | Post IPO | 9339063 | 7587134 | 3537252 | 6932125 |
2005 | 1264 | Series A | 1252 | 6491 | 6392 |
View details of Ergomed's funding rounds and investors
Ergomed's founders and board of directors
Founder? Claim ProfileErgomed's employee count trend
Ergomed has 1,437 employees as of Jan 22. The total employee count is 15.0% more than what it was in Jan 21. Here is Ergomed's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Ergomed's Competitors and alternates
Top competitors of Ergomed include TFS, Parexel and Syneos Health. Here is the list of Top 10 competitors of Ergomed, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | A global mid-service CRO providing clinical research services | - | - | 64/100 | |
2nd | Parexel 1983, Waltham (United States), Acquired | Global full-service CRO | - | 62/100 | |
3rd | Syneos Health 1984, Raleigh (United States), Public | Provider of CRO clinical development | - | 61/100 | |
4th | Siro Clinpharm 2000, Thane (India), Acquired | Company offering clinical development services | $5.25M | 60/100 | |
5th | Celgene 1986, Summit (United States), Acquired | Developer of therapies for treating cancer and inflammatory diseases | $45M | 56/100 | |
6th | Veristat 1994, Southborough (United States), Acquired | Clinical research organization accelerating complex therapies through strategic planning and execution | - | 56/100 | |
7th | Biorasi 2002, Miami (United States), Acquired | CRO delivering reliable, flexible, transparent clinical trials with scientific excellence | - | - | 56/100 |
8th | Provider of outsourced CRO services | - | 54/100 | ||
9th | hVIVO 1998, London (United Kingdom), Public | Provider of cell based assays, field trial, and molecular services for biopharma sector | - | 50/100 | |
10th | Premier Research 1989, Durham (United States), Public | Provider of clinical trial CRO services | - | 50/100 | |
13th | Ergomed 1997, Guildford (United Kingdom), Acquired | Clinical CRO specializing in oncology and rare diseases | - | 46/100 |
Looking for more details on Ergomed's competitors? Click here to see the top ones
Ergomed's Investments and acquisitions
Ergomed has made 1 investments in companies including Asarina Pharma. Ergomed has also acquired 10 companies including Panacea and ADAMAS Consulting.Here is the list of investments & acquisitions:
Filter this list
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Oct 10, 2023 | Acquisition | 2008 | Douglas (United Kingdom) | |
Feb 09, 2022 | Acquisition | 1997 | Crowthorne (United Kingdom) | |
Dec 14, 2020 | Acquisition | 1997 | Houston (United States) |
See all acquisitions by Ergomed
News related to Ergomed
•
•
Ergomed strongly positioned for future growth in new partnership with PermiraGlobeNewswire•Nov 14, 2023•Ergomed, Permira
•
•
fds Director Services advises on pharmacovigilance consultancy dealInsider Media•Oct 10, 2023•Fds, Panacea, Ergomed
•
Ergomed first-half profit firms ahead of agreed takeover by PermiraMorningstar•Sep 22, 2023•Ergomed, Permira
•
•
Permira Advisers’ £703.1 Million Recommended Takeover of ErgomedGlobal Legal Chronicle•Sep 14, 2023•Ergomed, Permira
•
Blackstone to provide private credit funding for Permira's Ergomed dealPrivate Equity Wire•Sep 05, 2023•Ergomed, Blackstone, Permira, Rothschild & Co
•
•
Are you a Founder ?
FAQs about Ergomed
Explore our recently published companies
- Suaexplosives - India based, Unfunded company
- Alpenglo Digital - Denver based, 2008 founded, Unfunded company
- Rambleon - Ger based, Funding Raised company
- FairDeal Wealth Advisors - Mumbai based, 2024 founded, Unfunded company
- Liver-Transfection - Unfunded company
- Wealthforest.com - 2014 founded, Unfunded company